Current and Future Treatment of Retinitis Pigmentosa

Cross N, van Steen C, Zegaoui Y, Satherley A, Angelillo L.

2022
Clin Ophthalmol

View publication

Therapeutic Area

Back of the eye (BOTE)
Technology

Gene / Cell Therapy
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

Affiliations

Market Access, Lightning Health, London, UK.; Market Access, Health Technology Assessment & Health Economics and Outcome Research, Europe, the Middle East and Africa, Santen GmbH, Munich, Bavaria, Germany

Related Publications

Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.

Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.

Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats

Yamamoto Y.; Taniguchi T.; Shimazaki A.

View all Back of the eye (BOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022